About Protein TESPA1
Protein TESPA1 (TESPA1) is a protein
from Homo sapiens identified by UniProt accession
A2RU30, 521 residues long.
MolForge cross-references it against 0 known binders and
125 disease associations.
Target properties
| Protein name | Protein TESPA1 |
| UniProt accession | A2RU30 |
| Gene | TESPA1 |
| Organism | Homo sapiens |
| Length | 521 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (125)
Diseases linked to this target (Open Targets).
- childhood onset asthma · score 0.45
- asthma · score 0.39
- Eczematoid dermatitis · score 0.39
- atopic asthma · score 0.31
- allergic rhinitis · score 0.31
- neurodegenerative disease · score 0.30
- allergic asthma · score 0.18
- genetic disorder · score 0.12
- atopic eczema · score 0.09
- acute myeloid leukemia · score 0.08
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-A2RU30-F1 | alphafold | PREDICTED | 53.94 | — |
Amino-acid sequence (521 residues)
MEASVLSPTS WEKRRAWLRQ SRNWQTQVLE EEAAAALQDV PDPEPSSLDD VFQEGNPINK IEDWLQDCGY SEEGFSEEAG QFIYNGFCSH GTSFEDDLTL GAEATLLAAN GKLFSRSFLE TARPCQLLDL GCSLASSSMT GGTNKTSSSI SEILDKVQED AEDVLFSLGF GQEDHKDTSR IPARFFTTPS QAKGIDFQLF LKSQVRRIEM EDPCLMLASR FKQVQTLAVT ADAFFCLYSY VSKTPVQKFT PSHMFWNCNH PTDVPSIRIL SREPEPQSPR DRLRKAISKM CLYTCPRDRP PPPHNTPKRN SLDQVVLEVM DKVKEEKQFL QQDSDLGQFS QEDPVPPAEG KKLPTSPYPC VFCCEEETQQ RMSTVLAPSQ TLDSNPKVPC CTHSLPIEDP QWSTDPAQIR RELCSLPATN TETHPAKDET FWKRKSRARK SLFQKNLMGR KVKSLDLSIT QQKWKQSVDR PELRRSLSQQ PQDTFDLEEV QSNSEEEQSQ SRWPSRPRHP HHHQTFAGKD S
Explore Protein TESPA1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets